Quantitative Microvasculature Imaging for Breast Cancer Detection and Monitoring

Recruiting

• Conditions: Breast Carcinoma; Breast Neoplasm

• Registration Number: NCT04799535
• Lead Sponsor: Mayo Clinic

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2021-3-10
• Last Update Posted: 2 September 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

Inclusion Criteria:<br><br> - AIM 1: Patient volunteers, ages >= 18 with suspicious breast masses scheduled for<br> breast biopsy, or at least two weeks or more after breast biopsy<br><br> - AIM 2: Patient volunteers, ages >= 18 who have biopsy proven breast cancer and are<br> going under neoadjuvant chemotherapy and/or endocrine therapy had their baseline MRI<br> and/or ultrasound<br><br>Exclusion Criteria:<br><br> - Patients with breast implants or any condition that does not allow proper use of<br> ultrasound (US)

Exclusion Criteria

Not provided

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Specificity of ultrasound in detection of breast cancer

Secondary Outcome Measures

Name	Time	Method
Accuracy in prediction of treatment response